As of 2026-02-04, the Relative Valuation of Verrica Pharmaceuticals Inc (VRCA) is (30.99) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.45 USD, the upside of Verrica Pharmaceuticals Inc based on Relative Valuation is -516.0%.
The range of the Relative Valuation is (31.01) - (32.70) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.1x - 20.3x | 18.8x |
| Forward P/E multiples | 19.1x - 20.1x | 19.3x |
| Fair Price | (31.01) - (32.70) | (30.99) |
| Upside | -516.2% - -538.9% | -516.0% |
| Date | P/E |
| 2026-02-02 | -4.58 |
| 2026-01-30 | -4.32 |
| 2026-01-29 | -4.43 |
| 2026-01-28 | -4.41 |
| 2026-01-27 | -4.49 |
| 2026-01-26 | -4.54 |
| 2026-01-23 | -4.56 |
| 2026-01-22 | -4.75 |
| 2026-01-21 | -4.77 |
| 2026-01-20 | -4.88 |
| 2026-01-16 | -4.46 |
| 2026-01-15 | -4.68 |
| 2026-01-14 | -4.89 |
| 2026-01-13 | -4.93 |
| 2026-01-12 | -4.93 |
| 2026-01-09 | -4.88 |
| 2026-01-08 | -4.93 |
| 2026-01-07 | -4.99 |
| 2026-01-06 | -4.95 |
| 2026-01-05 | -5.45 |
| 2026-01-02 | -5.10 |
| 2025-12-31 | -5.11 |
| 2025-12-30 | -5.10 |
| 2025-12-29 | -5.04 |
| 2025-12-26 | -5.02 |
| 2025-12-24 | -5.12 |
| 2025-12-23 | -5.05 |
| 2025-12-22 | -4.86 |
| 2025-12-19 | -4.81 |
| 2025-12-18 | -4.98 |
| 2025-12-17 | -4.95 |
| 2025-12-16 | -5.29 |
| 2025-12-15 | -4.65 |
| 2025-12-12 | -4.87 |
| 2025-12-11 | -5.10 |
| 2025-12-10 | -5.06 |
| 2025-12-09 | -5.08 |
| 2025-12-08 | -4.98 |
| 2025-12-05 | -5.42 |
| 2025-12-04 | -5.18 |
| 2025-12-03 | -4.60 |
| 2025-12-02 | -4.14 |
| 2025-12-01 | -4.64 |
| 2025-11-28 | -5.59 |
| 2025-11-26 | -4.12 |
| 2025-11-25 | -3.15 |
| 2025-11-24 | -2.90 |
| 2025-11-21 | -2.59 |
| 2025-11-20 | -2.47 |
| 2025-11-19 | -2.75 |